39
Participants
Start Date
March 13, 2014
Primary Completion Date
October 6, 2014
Study Completion Date
November 4, 2014
Placebo
Participants were directed to consume 1 placebo capsule containing maltodextrin, three times daily, for 90 days. Subjects were directed to consume the capsules with their three largest eating occasions of the day.
Candida cylindracea lipase (225,000 FIP lipase units per day)
Participants were directed to consume 1 capsule containing lipase (75,000 FIP lipase units per capsule), three times daily, for 90 days. Subjects were directed to consume the capsules with their three largest eating occasions of the day.
Candida cylindracea lipase (450,000 FIP lipase units per day)
Participants were directed to consume 2 capsules containing lipase (75,000 FIP lipase units per capsule), three times daily, for 90 days. Subjects were directed to consume the capsules with their three largest eating occasions of the day.
Candida cylindracea lipase (675,000 FIP lipase units per day)
Participants were directed to consume 2 capsules containing lipase (112,500 FIP lipase units per capsule), three times daily, for 90 days. Subjects were directed to consume the capsules with their three largest eating occasions of the day.
Atlantia Food Clinical Trials, Western Gateway Bldg, University College Cork, Cork
Collaborators (1)
Atlantia Food Clinical Trials
INDUSTRY
Cork University Hospital
OTHER
BIO-CAT, Inc.
INDUSTRY